Hemp Hucksters?

I saw a press release today for "Organic CBD oil made in America GreenLeaf Farms" that asserts that the company is "the first company to offer true all organic CBD oil made in America". The press release has two images, both of which link to the same page, near the bottom:

The website is: http://greenleaf.farm/investment-opportunity/

The investment pitch suggests:

Investment is in the common stock of the company. These shares entitle the holder to a fixed 25% ROI in 18 months.

Wow! That can't be legal to promise a return, can it? Here is the executive summary,

There are material math mistakes in their pretend P&L statement:

To their credit, unlike many outright scams, these guys include their names:

Stanley Abbott's bio above fails to include material information about his business dealings, as he is an executive at Phoenix Pharms Capital Corporation , the entity that is involved with (and controls) MediJane Holdings (MJMD). Given that this entity is similar to PPCC, one wonders why it isn't mentioned. Perhaps because it has been such a colossal failure!

Todd Mauney appears to be bad news. FINRA offers a "broker check", and his report indicates a sordid history:

The company misspells Mohyuddin Mirza, who appears to be accomplished in greenhouse farming. He appears to be consulting to Sundial Growers in Canada, which is an MMPR applicant that claims to be awaiting final inspection.Greenleaf Industries filed its incorporation in Texas on June 22nd, just 6 weeks ago. There is no indication that any principals have actually invested a dime in this enterprise thus far.

One final note is that the company stated it has a product for sale, including a price:

The first product GreenLeaf Farms is offing (sic) is a $99 500mg CBD oil ...
Read More
Comments

Good Info from the SEC

http://www.sec.gov/oiea/investor-alerts-bulletins/...

The SEC’s Office of Investor Education and Advocacy is issuing this Investor Alert to warn investors about fraudsters who promote a stock to drive up the stock price and then sell their own shares at the inflated price, making ...

Read More
Comments

Why PZOO May Move to New Lows

Today, Pazoo, Inc. (PZOO) filed another preliminary proxy in advance of a dramatic boost to its authorized shares. The company is raising its common share authorization by almost 2 billion to 2.95 billion from 0.98 billion. It is also increasing ...

Read More
Comments

Slides from Houlihan's Valuation of Kannaway for MJNA

5 weeks ago, MJNA announced that it was buying Kannaway, the MLM that distributes some of its products. The press release, which didn't detail the terms of the transaction, alluded to a valuation analysis performed by Houlihan Capital that suggested ...

Read More
Comments

A Good Time to Grab Some GW Pharma

UK-based GW Pharma (GWPH) is allowing long-term investors a good entry today following the release of Q1 results and a conference call that followed.  The stock continued to retrace a good portion of its massive rally in early January today but ...

Read More
Comments

MJNA: It's What They Didn't Say About Kannaway That Should Make You Run Away

In typical fashion for the company, Medical Marijuana, Inc. (MJNA) dropped an aggressive press release lacking substance in what appears to be a last-ditch effort to interest investors in its comatose stock.  Before the market opened on 1/22/15, the company ...

Read More
Comments

Red Ahead for this Black Eye of the Green Rush

In a move that has been signaled by a brewing battle, Medbox (MDBX) founder and controlling shareholder Vincent Mehdizadeh moved today to replace the entire Board of Directors.  In a definitive proxy filed with the SEC, Mehdizadeh named himself, employees Matthew ...

Read More
Comments

Pot Stocks Pay Off: A Review of the Cannabis Sector

NOTE:  This is satire

What a year it was for the marijuana sector, bouncing back from a challenging 2014. While the sector ended the year well below the 2014 highs despite more than tripling in price, investors are optimistic that ...

Read More
Comments

420 Investor Interview: Paul Rosen, CEO of PharmaCan Capital

One of the most exciting themes for those looking to capitalize on the changing global cannabis industry is the rollout of Canada's Marihuana for Medical Purposes Regulations (MMPR). Health Canada, which oversees Canada’s national medical marijuana program, has issued licenses ...

Read More
Comments

Election Survey 11/03/14 - Public Survey

420 Investor conducted a survey for the public that was exactly the same as its internal survey.  The public survey, which was posted on Twitter and Facebook, consisted of six questions and was open for 50 hours, closing at 9 A.M. EDT on 11/03, ...

Read More
Comments

Stay Informed with the 420 Investor Newsletter

After a year of helping investors navigate the "Wild West" of the cannabis stock sector as 420 Investor has evolved into the leading collaborative due diligence platform, we are pleased to offer the 420 Investor Newsletter.

This monthly effort is ...

Read More
Comments

GrowBLOX "Blows" It

GrowBLOX Sciences (GBLX) posted a press release this morning. This company has spent an enormous amount of money on p.r. and investor relations and has pushed the envelope (using GoogleAds, for instance, to promote its ticker). Shockingly, the company misspelled its ...

Read More
Comments